BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 813109)

  • 1. Characteristics of a microsomal dechlorination system.
    Van Dyke RA; Gandolfi AJ
    Mol Pharmacol; 1975 Nov; 11(6):809-17. PubMed ID: 813109
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
    Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
    Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the rate-limiting enzyme component in the microsomal monooxygenase system. Incorporation of purified NADPH-cytochrome c reductase and cytochrome P-450 into rat liver microsomes.
    Miwa GT; West SB; Lu AY
    J Biol Chem; 1978 Mar; 253(6):1921-9. PubMed ID: 416020
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of phenobarbital and 3,4-benzypyrene on microsomal cytochrome P-450 and NADPH-cytochrome C reductase in regenerating rat liver after partial hepatectomy or chemical injury.
    Katz DI; Stenger RJ; Johnson EA; Datta RK; Rice J
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):180-91. PubMed ID: 413503
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of NADPH cytochrome c reductase and cytochrome P-450 in hepatic microsomes to treatment with phenobarbital--differences in rat strains.
    Gold G; Widnell CC
    Biochem Pharmacol; 1975 Nov; 24(22):2105-6. PubMed ID: 813642
    [No Abstract]   [Full Text] [Related]  

  • 6. The NADPH-dependent cytochrome P-450 reduction in liver microsomes of rats of different ages with and without phenobarbital pretreatment.
    Müller D; Lübbe H; Klinger W
    Acta Biol Med Ger; 1975; 34(8):1333-7. PubMed ID: 1210995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and properties of highly purified cytochrome p-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits.
    Guengerich FP
    Mol Pharmacol; 1977 Sep; 13(5):911-23. PubMed ID: 408601
    [No Abstract]   [Full Text] [Related]  

  • 8. Circadian changes of cytochrome P-450-dependent monooxygenase system in the rat liver.
    Plewka A; Czekaj P; Kamiński M; Plewka D
    Pol J Pharmacol Pharm; 1992; 44(6):655-61. PubMed ID: 1305961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH-cytochrome c reductase, cytochrome P-450 and NADPH-linked lipid peroxidation in microsomal fractions obtained from rat tissue.
    Benedetto C; Slater TF; Dianzani MU
    Biochem Soc Trans; 1976; 4(6):1094-7. PubMed ID: 828591
    [No Abstract]   [Full Text] [Related]  

  • 10. Rate-limiting step in the reconstituted microsomal drug hydroxylase system.
    Imai Y; Sato R; Iyanagi T
    J Biochem; 1977 Nov; 82(5):1237-46. PubMed ID: 412842
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction in hepatic microsomal cytochromes P-450 and b5 in rats exposed to 1,2-dibromo-3-chloropropane and carbon tetrachloride: enhancement of effect by pretreatment with phenobarbital.
    Moody DE; Head B; Smuckler EA
    J Environ Pathol Toxicol; 1979 Dec; 3(1-2):177-90. PubMed ID: 121136
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver microsomal drug-metabolizing enzyme system: functional components and their properties.
    Lu AY
    Fed Proc; 1976 Nov; 35(13):2460-3. PubMed ID: 824157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic compounds. Their interaction with and degradation of hepatic microsomal drug-metabolizing enzymes in vitro.
    Ivanetich KM; Lucas S; Marsh JA; Ziman MR; Katz ID; Bradshaw JJ
    Drug Metab Dispos; 1978; 6(3):218-25. PubMed ID: 26540
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and properties of cytochrome P-450 and NADPH-cytochrome c (P-450) reductase from human liver microsomes.
    Kamataki T; Sugiura M; Yamazoe Y; Kato R
    Biochem Pharmacol; 1979 Jul; 28(13):1993-2000. PubMed ID: 113009
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical studies of isolated rat hepatocytes from normal and phenobarbital-treated liver as obtained by rate zonal centrifugation.
    Weigand K; Richter E; Esperer HD
    Acta Hepatogastroenterol (Stuttg); 1977 Jun; 24(3):170-4. PubMed ID: 407768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron-transport cytochrome P-450 system is involved in the microsomal metabolism of the carcinogen chromate.
    Garcia JD; Jennette KW
    J Inorg Biochem; 1981 Jul; 14(4):281-95. PubMed ID: 6792322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of phenobarbital administration on hepatic monooxygenase activity at various stages of gestation in the rat.
    Dean ME; Stock BH
    Drug Metab Dispos; 1989; 17(5):579-81. PubMed ID: 2573504
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the activities of the hepatic and renal mixed function oxidase (MFO) systems in rats during different postnatal periods of life].
    Czekaj P; Plewka A
    Folia Med Cracov; 1990; 31(3):225-36. PubMed ID: 2129035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH-cytochrome c reductase and its role in microsomal cytochrome P-450-dependent reactions.
    Masters BS; Nelson EB; Schacter BA; Baron J; Isaacson EL
    Drug Metab Dispos; 1973; 1(1):121-8. PubMed ID: 4129865
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of proteinase K on the components of the liver microsomal cytochrome P-450 mixed function oxidase system.
    Shen TL; Zhuang ZP; McCauley R; Putt D; Hollenberg PF
    Drug Metab Dispos; 1991; 19(6):1016-21. PubMed ID: 1687005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.